420 related articles for article (PubMed ID: 16988018)
1. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease.
Scanlan PD; Shanahan F; O'Mahony C; Marchesi JR
J Clin Microbiol; 2006 Nov; 44(11):3980-8. PubMed ID: 16988018
[TBL] [Abstract][Full Text] [Related]
2. Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition.
Shiga H; Kajiura T; Shinozaki J; Takagi S; Kinouchi Y; Takahashi S; Negoro K; Endo K; Kakuta Y; Suzuki M; Shimosegawa T
Dig Liver Dis; 2012 Sep; 44(9):736-42. PubMed ID: 22622202
[TBL] [Abstract][Full Text] [Related]
3. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
[TBL] [Abstract][Full Text] [Related]
4. Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell sorting and 16S rRNA gene analysis.
Ben-Amor K; Heilig H; Smidt H; Vaughan EE; Abee T; de Vos WM
Appl Environ Microbiol; 2005 Aug; 71(8):4679-89. PubMed ID: 16085863
[TBL] [Abstract][Full Text] [Related]
5. Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.
Kolho KL; Korpela K; Jaakkola T; Pichai MV; Zoetendal EG; Salonen A; de Vos WM
Am J Gastroenterol; 2015 Jun; 110(6):921-30. PubMed ID: 25986361
[TBL] [Abstract][Full Text] [Related]
6. Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers.
Vanhoutte T; Huys G; Brandt E; Swings J
FEMS Microbiol Ecol; 2004 Jun; 48(3):437-46. PubMed ID: 19712312
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterisation of the faecal microbiota in patients with type II diabetes.
Wu X; Ma C; Han L; Nawaz M; Gao F; Zhang X; Yu P; Zhao C; Li L; Zhou A; Wang J; Moore JE; Millar BC; Xu J
Curr Microbiol; 2010 Jul; 61(1):69-78. PubMed ID: 20087741
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of the gut microbiota of identical twins with Crohn's disease.
Dicksved J; Halfvarson J; Rosenquist M; Järnerot G; Tysk C; Apajalahti J; Engstrand L; Jansson JK
ISME J; 2008 Jul; 2(7):716-27. PubMed ID: 18401439
[TBL] [Abstract][Full Text] [Related]
9. Microbial Population Differentials between Mucosal and Submucosal Intestinal Tissues in Advanced Crohn's Disease of the Ileum.
Chiodini RJ; Dowd SE; Chamberlin WM; Galandiuk S; Davis B; Glassing A
PLoS One; 2015; 10(7):e0134382. PubMed ID: 26222621
[TBL] [Abstract][Full Text] [Related]
10. The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease.
Sha S; Xu B; Wang X; Zhang Y; Wang H; Kong X; Zhu H; Wu K
Diagn Microbiol Infect Dis; 2013 Mar; 75(3):245-51. PubMed ID: 23276768
[TBL] [Abstract][Full Text] [Related]
11. Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: a pilot study.
De Cruz P; Kang S; Wagner J; Buckley M; Sim WH; Prideaux L; Lockett T; McSweeney C; Morrison M; Kirkwood CD; Kamm MA
J Gastroenterol Hepatol; 2015 Feb; 30(2):268-78. PubMed ID: 25087692
[TBL] [Abstract][Full Text] [Related]
12. Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease.
Andoh A; Kuzuoka H; Tsujikawa T; Nakamura S; Hirai F; Suzuki Y; Matsui T; Fujiyama Y; Matsumoto T
J Gastroenterol; 2012 Dec; 47(12):1298-307. PubMed ID: 22576027
[TBL] [Abstract][Full Text] [Related]
13. Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii.
Vanhoutte T; De Preter V; De Brandt E; Verbeke K; Swings J; Huys G
Appl Environ Microbiol; 2006 Sep; 72(9):5990-7. PubMed ID: 16957220
[TBL] [Abstract][Full Text] [Related]
14. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon.
Seksik P; Rigottier-Gois L; Gramet G; Sutren M; Pochart P; Marteau P; Jian R; Doré J
Gut; 2003 Feb; 52(2):237-42. PubMed ID: 12524406
[TBL] [Abstract][Full Text] [Related]
15. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease.
Takaishi H; Matsuki T; Nakazawa A; Takada T; Kado S; Asahara T; Kamada N; Sakuraba A; Yajima T; Higuchi H; Inoue N; Ogata H; Iwao Y; Nomoto K; Tanaka R; Hibi T
Int J Med Microbiol; 2008 Jul; 298(5-6):463-72. PubMed ID: 17897884
[TBL] [Abstract][Full Text] [Related]
16. Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray.
Kang S; Denman SE; Morrison M; Yu Z; Dore J; Leclerc M; McSweeney CS
Inflamm Bowel Dis; 2010 Dec; 16(12):2034-42. PubMed ID: 20848492
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent association of gut bacteria with coronary atherosclerosis: Tampere Sudden Death Study.
Tuomisto S; Huhtala H; Martiskainen M; Goebeler S; Lehtimäki T; Karhunen PJ
PLoS One; 2019; 14(8):e0221345. PubMed ID: 31437200
[TBL] [Abstract][Full Text] [Related]
18. Altered Fecal Microbiota in Paediatric Inflammatory Bowel Disease.
Maukonen J; Kolho KL; Paasela M; Honkanen J; Klemetti P; Vaarala O; Saarela M
J Crohns Colitis; 2015 Dec; 9(12):1088-95. PubMed ID: 26351391
[TBL] [Abstract][Full Text] [Related]
19. Terminal restriction fragment length polymorphism analysis of the gut microbiota profiles of pediatric patients with inflammatory bowel disease.
Aomatsu T; Imaeda H; Fujimoto T; Takahashi K; Yoden A; Tamai H; Fujiyama Y; Andoh A
Digestion; 2012; 86(2):129-35. PubMed ID: 22846404
[TBL] [Abstract][Full Text] [Related]
20. Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case-control study in India.
Kabeerdoss J; Sankaran V; Pugazhendhi S; Ramakrishna BS
BMC Gastroenterol; 2013 Jan; 13():20. PubMed ID: 23351032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
